ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding ADC Therapeutics SA changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 49 | 2 | 58 | +11 |
| Shares | 34.1M | 1.55M | 34.5M | +1.90M (+5.8%) |
| Value | $501.3M | $22.7M | $274.1M | −$204.5M (−42.7%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held ADC Therapeutics SA at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GCM Grosvenor Holdings, LLC | 1,298,012 | $10.3M | 2.33% |
| ExodusPoint Capital Management, LP | 139,192 | $1.11M | 0.02% |
| Balyasny Asset Management LLC | 86,100 | $684.0K | 0.00% |
| Renaissance Technologies LLC | 79,900 | $635.0K | 0.00% |
| Endurant Capital Management LP | 58,967 | $469.0K | 0.18% |
| Millennium Management LLC | 57,965 | $461.0K | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 38,700 | $308.0K | 0.02% |
| Woodline Partners LP | 33,841 | $269.0K | 0.00% |
| Lazard Asset Management LLC | 16,098 | $127.0K | 0.00% |
| State Street Corp | 14,028 | $112.0K | 0.00% |
| Graham Capital Management, L.P. | 12,992 | $103.0K | 0.00% |
| Squarepoint Ops LLC | 11,014 | $88.0K | 0.00% |
| Cypress Capital Group | 10,000 | $80.0K | 0.01% |
| Quantbot Technologies LP | 4,852 | $38.0K | 0.00% |
| Venture Visionary Partners LLC | 100 | $795 | 0.00% |
Sold out (4)
Institutions that held ADC Therapeutics SA at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Virtus ETF Advisers LLC | 19,193 | $282.0K |
| Prospera Financial Services Inc | 5,921 | $87.0K |
| State of Wyoming | 2,882 | $42.0K |
| CWM, LLC | 950 | $14.0K |
Not filed for Q2 2022 yet (2)
Institutions that held ADC Therapeutics SA at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22.3M |
| Susquehanna Fundamental Investments, LLC | 28,949 | $425.0K |